DXSA:XETRA:XETRA-Xtrackers - Euro Stoxx Select Dividend 30 UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 22.585

Change

+0.03 (+0.13)%

Market Cap

USD 0.26B

Volume

8.99K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-16 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.05 (-0.09%)

USD 446.30B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.02 (-0.14%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.07 (-0.26%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.10 (-0.34%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.08 (+0.30%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.02 (+0.04%)

USD 104.21B
8R80:XETRA Amundi Index Solutions - Amund..

-0.82 (-0.59%)

USD 102.09B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.10 (-0.19%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.33 (+0.31%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+0.92 (+0.15%)

USD 80.38B

ETFs Containing DXSA:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.82% 83% B 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.82% 83% B 79% B-
Trailing 12 Months  
Capital Gain 11.42% 48% F 51% F
Dividend Return 5.11% 90% A- 82% B
Total Return 16.53% 59% D- 60% D-
Trailing 5 Years  
Capital Gain -0.04% 31% F 38% F
Dividend Return 22.79% 97% N/A 87% B+
Total Return 22.75% 47% F 50% F
Average Annual (5 Year Horizon)  
Capital Gain 5.20% 46% F 47% F
Dividend Return 8.12% 56% F 55% F
Total Return 2.92% 97% N/A 84% B
Risk Return Profile  
Volatility (Standard Deviation) 12.01% 53% F 62% D
Risk Adjusted Return 67.63% 58% F 63% D
Market Capitalization 0.26B 51% F 45% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike